These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 27503494)
21. Trends in bilateral mastectomy rates among different racial backgrounds: A National Cancer Database study. Nicholson K; Kuchta K; Fefferman M; Pesce C; Kopkash K; Poli E; Yao K Am J Surg; 2023 Oct; 226(4):455-462. PubMed ID: 37429752 [TBL] [Abstract][Full Text] [Related]
22. Utilization of breast conserving therapy in stages 0, I, and II breast cancer patients in New Jersey: an American College of Surgeons National Cancer Data Base (NCDB) analysis. Daroui P; Gabel M; Khan AJ; Haffty BG; Goyal S Am J Clin Oncol; 2012 Apr; 35(2):130-5. PubMed ID: 21325935 [TBL] [Abstract][Full Text] [Related]
23. Racial and Ethnic Differences in Tobacco Information Seeking and Information Sources: Findings From the 2015 Health Information National Trends Survey. Nguyen AB; Robinson J; O'Brien EK; Zhao X J Health Commun; 2017 Sep; 22(9):743-752. PubMed ID: 28762887 [TBL] [Abstract][Full Text] [Related]
24. The Effect of Receptor Status on Mastectomy and Contralateral Prophylactic Mastectomy Rates in Early Stage Invasive Breast Carcinoma. Dutta SW; Trifiletti DM; Grover S; Romano KD; Janowski EM; Showalter SL Clin Breast Cancer; 2018 Apr; 18(2):121-127. PubMed ID: 28811185 [TBL] [Abstract][Full Text] [Related]
25. Racial/ethnic variation and risk factors for allopurinol-associated severe cutaneous adverse reactions: a cohort study. Keller SF; Lu N; Blumenthal KG; Rai SK; Yokose C; Choi JWJ; Kim SC; Zhang Y; Choi HK Ann Rheum Dis; 2018 Aug; 77(8):1187-1193. PubMed ID: 29653927 [TBL] [Abstract][Full Text] [Related]
26. Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative. Livaudais JC; Lacroix A; Chlebowski RT; Li CI; Habel LA; Simon MS; Thompson B; Erwin DO; Hubbell FA; Coronado GD Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):365-73. PubMed ID: 23275187 [TBL] [Abstract][Full Text] [Related]
27. Characteristics and treatment of human epidermal growth factor receptor 2 positive breast cancer: 43,485 cases from the National Cancer Database treated in 2010 and 2011. Killelea BK; Chagpar AB; Horowitz NR; Lannin DR Am J Surg; 2017 Feb; 213(2):426-432. PubMed ID: 27769548 [TBL] [Abstract][Full Text] [Related]
29. Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy. Petruolo OA; Pilewskie M; Patil S; Barrio AV; Stempel M; Wen HY; Morrow M Ann Surg Oncol; 2017 Sep; 24(9):2556-2562. PubMed ID: 28560596 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States. Daly B; Olopade OI; Hou N; Yao K; Winchester DJ; Huo D JAMA Oncol; 2017 Jul; 3(7):928-935. PubMed ID: 28152150 [TBL] [Abstract][Full Text] [Related]
31. The use of adjuvant radiation therapy in male breast cancer and its impact on outcomes. Bakalov V; Jayakrishnan TT; Abel S; Hilton C; Rusia B; Wegner RE Cancer Treat Res Commun; 2021; 27():100359. PubMed ID: 33812181 [TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the National Cancer Database. Killelea BK; Yang VQ; Mougalian S; Horowitz NR; Pusztai L; Chagpar AB; Lannin DR J Am Coll Surg; 2015 Jun; 220(6):1063-9. PubMed ID: 25868410 [TBL] [Abstract][Full Text] [Related]
33. Racial and ethnic disparities in the use of intravenous recombinant tissue plasminogen activator and outcomes for acute ischemic stroke. Nasr DM; Brinjikji W; Cloft HJ; Rabinstein AA J Stroke Cerebrovasc Dis; 2013 Feb; 22(2):154-60. PubMed ID: 22155116 [TBL] [Abstract][Full Text] [Related]
34. Disparities in mortality-to-incidence ratios by race/ethnicity for female breast cancer in New York City, 2002-2016. Nobel TB; Asumeng CK; Jasek J; Van Beck KC; Mathur R; Qiao B; Brown JJ Cancer Med; 2020 Nov; 9(21):8226-8234. PubMed ID: 33006431 [TBL] [Abstract][Full Text] [Related]
35. Contextual factors and weight change over time: a comparison between U.S. Hispanics and other population sub-groups. Ullmann SH; Goldman N; Pebley AR Soc Sci Med; 2013 Aug; 90():40-8. PubMed ID: 23746607 [TBL] [Abstract][Full Text] [Related]
36. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. Elledge RM; Clark GM; Chamness GC; Osborne CK J Natl Cancer Inst; 1994 May; 86(9):705-12. PubMed ID: 7908990 [TBL] [Abstract][Full Text] [Related]
37. Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results. Press DJ; Ibraheem A; Dolan ME; Goss KH; Conzen S; Huo D Breast Cancer Res Treat; 2018 Feb; 168(1):207-220. PubMed ID: 29181717 [TBL] [Abstract][Full Text] [Related]
38. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California. Parise C; Caggiano V Cancer Epidemiol; 2014 Oct; 38(5):556-62. PubMed ID: 25172158 [TBL] [Abstract][Full Text] [Related]